Zemplar and oedema peripheral Patient Reports February 10, 2012

Zemplar Side Effects Report #5530386-6
Zemplar side effect was reported by a Physician from UNITED STATES on Oct 30, 2007. Male patient, weighting 178.2 lb, was diagnosed with vitamin supplementation and was treated with Zemplar. After drug was administered, patient experienced the following side effects: joint swelling, oedema peripheral, pruritus, rash erythematous. Zemplar dosage: unknown. Patient recovered.

Zemplar Side Effects Report #5576828-1
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Dec 22, 2007. Male patient, 70 years of age, weighting 144.0 lb, was diagnosed with secondary hypothyroidism, insomnia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthenia, blood glucose decreased, blood glucose increased, dialysis device complication, fall , fatigue, haematoma, oedema peripheral, pain . Zemplar dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, INSULIN, INSULIN NOVOMIX. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5694995-6
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Mar 26, 2008. Male patient, 70 years of age, weighting 144.0 lb, was diagnosed with secondary hypothyroidism, insomnia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthenia, blood glucose decreased, blood glucose increased, dialysis device complication, fall , fatigue, haematoma, oedema peripheral, pain . Zemplar dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, INSULIN, INSULIN NOVOMIX. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5176645-0
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Oct 31, 2006. Female patient, weighting 244.7 lb, was diagnosed with renal failure chronic, hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, calciphylaxis, cardiac failure, diarrhoea, hyperparathyroidism secondary, international normalised ratio increased, oedema peripheral, pain in extremity, skin necrosis. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN BETA, SOTALOL HYDROCHLORIDE, FERRIECIT, GODASAL, NAHCO, CACO, SEVELAMER HYDROCHLORIDE. Patient was hospitalized. Patient died on 09/08/2006.


Zemplar Side Effects Report #5530385-4
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2007. Male patient, weighting 163.1 lb, was diagnosed with renal failure chronic, hypertension, thrombosis prophylaxis and was treated with Zemplar. After drug was administered, patient experienced the following side effects: muscle spasms, oedema peripheral. Zemplar dosage: unknown. During the same period patient was treated with OLMESARTAN MEDOXOMIL, WARFARIN. Patient recovered.

Zemplar Side Effects Report #5200141-5
Zemplar side effect was reported by a Physician from GERMANY on Dec 28, 2006. Male patient, weighting 207.2 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: angina pectoris, cardiac failure congestive, dyspnoea, electrocardiogram change, nausea , oedema peripheral, pleuritic pain, productive cough. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5234695-X
Zemplar side effect was reported by a Physician from GERMANY on Feb 01, 2007. Male patient, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, hypotension, oedema peripheral. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5236382-0
Zemplar side effect was reported by a Physician from GERMANY on Feb 03, 2007. Male patient, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, hypotension, oedema peripheral, pleural effusion. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5243125-3
Zemplar side effect was reported by a Physician from GERMANY on Feb 12, 2007. Male patient, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, hypotension, oedema peripheral. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.


Zemplar Side Effects Report #5253812-9
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Jan 19, 2007. Male patient, weighting 200.6 lb, was diagnosed with hyperparathyroidism secondary, myocardial ischaemia, coronary artery insufficiency and was treated with Zemplar. After drug was administered, patient experienced the following side effects: catheter related complication, coronary artery insufficiency, myocardial ischaemia, oedema peripheral. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, FUROSEMIDE, TELMISARTAN, MIRIL, PREDUCTAL MR, SEVELAMER HYDROCHLORIDE, RILMENIDINE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #4974453-4
Zemplar side effect was reported by a Physician from SPAIN on Mar 28, 2006. Male patient, weighting 123.5 lb, was diagnosed with hyperparathyroidism secondary, hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, cardiac failure, congestive cardiomyopathy, dyspnoea, electrocardiogram st segment elevation, ischaemic cardiomyopathy, mitral valve incompetence, oedema peripheral, orthopnoea. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, FOLIC ACID, TAMSULOSIN, VITAMINES, OMEPRAZOLE, EPOETIN ALFA, SEVELAMER HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5875716-0
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Sept 04, 2008. Male patient, 48 years of age, weighting 132.7 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acinetobacter infection, enterococcal infection, fatigue, feeling hot, impaired healing, ischaemia, malaise, oedema peripheral, osteitis. Zemplar dosage: 5 MCG/ML, 20 MCG/WEEK. During the same period patient was treated with PARENTROVITE, DEXTROPROPOXYPHENE NAPSILATE, SIMVASTATIN, CLOPIDOGREL, BICARBONATE, ALLOPURINOL, AMITRIPTYLINE HYDROCHLORIDE, MINTARA. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5954021-8
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 04, 2008. Female patient, weighting 264.2 lb, was diagnosed with hyperparathyroidism, mineral supplementation, prophylaxis, swelling, coronary arterial stent insertion, diabetes mellitus and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cartilage injury, fall , haemorrhage, oedema peripheral, skin laceration, wound necrosis. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, POTASSIUM CHLORIDE, FUROSEMIDE, CLOPIDOGREL, SITAGLIPTIN PHOSPHATE, PIOGLITAZONE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5955611-9
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 17, 2008. Female patient, weighting 264.2 lb, was diagnosed with hyperparathyroidism, mineral supplementation, prophylaxis, swelling, coronary arterial stent insertion, diabetes mellitus and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cartilage injury, fall , haemorrhage, oedema peripheral, skin laceration, wound necrosis. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, POTASSIUM CHLORIDE, FUROSEMIDE, CLOPIDOGREL, SITAGLIPTIN PHOSPHATE, PIOGLITAZONE. Patient was hospitalized. Patient recovered.


Zemplar Side Effects Report #5859163-3
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Aug 19, 2008. Male patient, 48 years of age, was treated with Zemplar. After drug was administered, patient experienced the following side effects: acinetobacter infection, enterococcal infection, fatigue, feeling hot, impaired healing, ischaemia, malaise, oedema peripheral, osteitis. Zemplar dosage: 5 MCG/ML, 20 MCG/WEEK. During the same period patient was treated with PARENTROVITE, DEXTROPROPOXYPHENE NAPSILATE, SIMVASTATIN, CLOPIDOGREL, BICARBONATE, ALLOPURINOL, AMITRIPTYLINE HYDROCHLORIDE, MINTARA. Patient was hospitalized. Patient recovered.